The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 1993

C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
Division and Chair of Hematology, Udine University Hospital, Italy.

BACKGROUND More than 50% of adults with acute lymphoblastic leukemia (ALL) actually die with resistant leukemia. The multidrug resistance (MDR) related P170 glycoprotein may be involved in treatment failure. METHODS P170 content of leukemic cells was assayed by immunocytochemistry with the MRK-16 monoclonal antibody in 41 consecutive cases of adult ALL (27 at onset and 14 at relapse). RESULTS Positive cells were found in 11/14 cases at relapse and in 18/27 cases at onset. All cases with a high WBC, FAB L3, B-mature phenotype, and t(9; 22) were positive. In the 27 patients who were studied at onset and were treated with the same protocol, the overall failure rate was 44% in negative cases and 83% in positive cases. CONCLUSIONS P170 overexpression may contribute to drug resistance and to chemotherapy failure in adult ALL.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma

Related Publications

C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
December 1993, Blood,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
November 1995, Leukemia,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
September 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
December 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
March 2002, British journal of haematology,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
November 1992, Leukemia & lymphoma,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
May 1998, Annals of hematology,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
January 2000, Journal of pediatric hematology/oncology,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
May 1993, Blood,
C Savignano, and A Geromin, and M Michieli, and D Damiani, and A Michelutti, and C Melli, and R Fanin, and M Baccarani
January 1995, Leukemia & lymphoma,
Copied contents to your clipboard!